Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Probiosphere is a Canadian environmental biotechnology company focused on industrial and municipal wastewater treatment, environmental remediation, and biogas-related applications. Founded in 2015 in Quebec, the company develops and commercializes biological and enzyme-based solutions, including microbial consortia and phosphorus-removal technologies, to treat contaminants such as organics, ammonia, cyanide, phosphorus, and heavy metals. Its offerings are positioned as performance-based services for wastewater and surface-water treatment rather than as a drug-development pipeline. Probiosphere also applies its technologies to sludge management, odor control, algae treatment, soil decontamination, and methane-producing plants. The company appears to be an active private company with commercial operations in Canada, the United States, and selected markets in Europe and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Probiosphere.